Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001401914-21-000137
Filing Date
2021-11-10
Accepted
2021-11-10 16:02:32
Documents
59
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q dare-20210930.htm   iXBRL 10-Q 1191685
2 EX-10.1 ex101.htm EX-10.1 25586
3 EX-10.2 ex102.htm EX-10.2 159264
4 EX-31.1 exhibit311_20210930.htm EX-31.1 15481
5 EX-31.2 exhibit312_20210930.htm EX-31.2 15237
6 EX-32.1 exhibit321_20210930.htm EX-32.1 4352
7 EX-32.2 exhibit322_20210930.htm EX-32.2 4340
13 dare-20210930_g1.jpg GRAPHIC 130914
14 image_0a.jpg GRAPHIC 1976
  Complete submission text file 0001401914-21-000137.txt   5910072

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dare-20210930.xsd EX-101.SCH 45748
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dare-20210930_cal.xml EX-101.CAL 40751
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dare-20210930_def.xml EX-101.DEF 197192
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dare-20210930_lab.xml EX-101.LAB 516712
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dare-20210930_pre.xml EX-101.PRE 314641
15 EXTRACTED XBRL INSTANCE DOCUMENT dare-20210930_htm.xml XML 729483
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

EIN.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36395 | Film No.: 211396445
SIC: 2834 Pharmaceutical Preparations